MELISSA SHERMAN: Open Payments
NPI 1013534692 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 10 payments from 8 companies in 2025. Trend: 2023 $177 · 2024 $539 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Janssen Biotech, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Braintree Laboratories, Inc. | 1 | $15 |
Products named: ENTYVIO, VOQUEZNA, TREMFYA, RINVOQ, IQIRVO, Cologuard Collection Kit, DUPIXENT, SUFLAVE.
Industry payments across NY — which companies pay providers there.
